Pittsburgh based Sharp Edge Labs, a former NSIV member company, announced that it has entered into a drug discovery collaboration agreement with Sumitomo Dainippon Pharma Co. Ltd. Sharp Edge focuses on discovering drugs to treat genetic disorders of protein trafficking. CEO Scott Sneddon explained that the collaboration “takes advantage of the synergy between Sumitomo Dainippon Pharma’s expertise in CNS drug discovery and development, and Sharp Edge’s unique cellular biosensor technology.”
August 25th, 2016 Funding will go towards expanding the region’s biotech industry with a new business incubator space Salem, MA – Today, the Office of Congressman Seth Moulton (D-MA) announced that the U.S. Department of Commerce¹s Economic Development Administration (EDA) has awarded a $1.4 million dollar grant to Endicott College and North Shore InnoVentures in Beverly. This investment will create nearly 350 new jobs in the district and significantly expand the region¹s biotech industry, while spurring private investment in the life sciences sector. “This substantial federal investment in Beverly will expand our region’s biotech innovation sector and create nearly 400 jobs right here in the district,” said Congressman Seth Moulton. “I’m grateful to the Department of Commerce for making an investment that will enhance economic development, create new jobs, and solidify our state¹s role as a national leader in the life-sciences industry.”
Woman-led technology incubator will boost efforts to support entrepreneurs developing biotech and cleantech startups BEVERLY, Massachusetts, September 1, 2016. North Shore InnoVentures (NSIV), one of New England’s leading technology incubators and business accelerators, announced today that it received a highly competitive award for $50,000 from U.S. Small Business Administration’s Accelerator Growth Fund Competition. NSIV was one of only three award winners in the Commonwealth of Massachusetts. In the third year of the award, the SBA received over 400 applicants. In total $3.4 million will be distributed to 68 winners to boost the economic impact of accelerators across 32 states and the District of Columbia and to continue building the support structure needed to help startups become commercially viable and create jobs more quickly.
Learn more about NSIV, featured in this video clip taken from the Beverly Economic Development Showcase held June 1, 2016.
August 15, 2016 – “Grow North, Young Biotech Startup” as posted by Travis McCready, President & CEO, Mass Life Sciences Center
Thrive Bioscience, a manufacturer of automated cell culture management systems, and the Harvard Stem Cell Institute (HSCI), Cambridge, Massachusetts, announced an agreement last week under which Thrive will develop instruments for the growth and maintenance of induced pluripotent stem cells (iPSCs). The agreement includes development of automated iPSC protocols critical to HSCI and its researchers. HSCI plans to utilize the Thrive systems within the Harvard Stem Cell Institute iPS Core Facility and affiliated research sites.
NSIV member, CrowdComfort, was featured in the WSJ last week in an article about high tech approaches being used to resolve the constant battle around the office thermostat. In addition to reporting uncomfortable conditions, CrowdComfort’s app leverages crowd-sourced occupant feedback to improve safety and operations in workplaces, unlock efficiencies in facilities management and preventative maintenance, increase employee productivity, and more.
NSIV member, Cellanyx Diagnostics, was awarded the best prostate cancer biomarker poster presentation at the recent 2016 American Urological Association annual meeting. “Cellanyx is currently developing phenotypic tests to address an important unmet clinical need in prostate cancer risk stratification by providing quantitative assessment of tumor aggressiveness and metastatic potential that complements the standard-of-care Gleason pathology scores”, according to the press release.
The Elevator Pitch: Sell Them on Your Idea, Your Product, Your Company, You!